XPXenia Ilinichna Plahova

Xenia Ilinichna Plahova

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Xenia Ilinichna Plahova has a total of 58 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Bovhyaluronidase azoximer in combination therapy for recurrent bacterial vaginosis: results of an open-label randomized controlled trial

    by Leonid G. Spivak, Спивак Леонид Григорьевич, Ksenia A. Rossolovskaya, Россоловская Ксения Антоновна, Igor I. Baranov, Баранов Игорь Иванович, Inna A. Apolikhina, Аполихина Инна Анатольевна, Gyuldana R. Bayramova, Байрамова Гюльдана Рауфовна, et al.

    Background. Recurrence of bacterial vaginosis (BV) after antibacterial therapy may be associated with the persistence of polymicrobial biofilms. Aim. To compare the efficacy and safety of metronidazole combined with bovhyaluronidase azoximer versus metronidazole monotherapy in recurrent BV. Materials and methods. In this open-label randomized two-center phase IV study, 100 women aged 18–45 years were randomized 1:1 to receive metronidazole monotherapy (500 mg twice daily for 7 days) or the same metronidazole regimen combined with bovhyaluronidase azoximer (3,000 IU intravaginally every other day for 10 administrations). Treatment efficacy at day 21 was assessed in 95 participants, while recurrence over 6 months was evaluated in 57 participants who achieved remission. Amsel criteria were used to diagnose BV and assess remission and recurrence. Light microscopy was used to detect clue cells and characterize the vaginal flora; culture and real-time polymerase chain reaction were used to assess cultivable microorganisms and quantitatively characterize the vaginal microbiota, respectively. Polymicrobial biofilms were visualized using transmission electron microscopy. Results. At day 21, a successful treatment outcome was achieved in 41/47 (87.2%) participants receiving combination therapy and 25/48 (52.1%) receiving monotherapy (p0.001). Combination therapy was associated with more frequent detection of rod-shaped flora in vaginal discharge (66.0% vs 43.8%; p=0.040), a higher relative abundance of Lactobacillus spp. (p=0.004), and a lower proportion of obligate anaerobes according to polymerase chain reaction (p=0.007). Culture detected Lactobacillus spp. in 80.9% versus 66.7% and Gardnerella vaginalis in 6.4% versus 18.8% of participants, respectively. Biofilms persisted in 4/47 (8.5%) and 25/48 (52.1%) participants, respectively (p0.001). At 6 months, recurrence occurred in 4/35 (11.4%) and 9/22 (40.9%) women (p=0.021), the Cox model hazard ratio for combination therapy versus monotherapy was 0.23 (95% confidence interval 0.07–0.76). Adverse events were reported in 7/100 participants. Conclusion. Adding bovhyaluronidase azoximer to metronidazole increased the remission rate, promoted restoration of the lactobacillus-dominated microbiota, reduced biofilm persistence and BV recurrence, and was associated with a favorable safety profile.

  • Open Access

    Late сardiovascular syphilis

    by Margarita R. Rakhmatulina, Georgiy L. Katunin, Xenia I. Plakhova, Mikhail M. Vasiliev, Плахова Ксения Ильинична, Васильев Михаил Михайлович

    Since 1998, there has been an annual decrease in the incidence of syphilis in the Russian Federation; however, in 2021 and 2022, the incidence increased, compared to 2020, by 38 and 30%, respectively. In addition, for the first time in many years, the incidence of late syphilis (8.0 cases per 100,000 population) exceeded the incidence of early forms (7.2 cases per 100,000 population). The article presents a case report of late cardiovascular syphilis in a patient who had previously received treatment for the disease. The diagnosis of late cardiovascular syphilis was based on the patient’s medical history, clinical examination, serological blood tests and instrumental diagnostic methods, including transesophageal echocardiography and multispiral computed tomography, i.e., panarthrography of the thoracic and abdominal aorta. The patient has aortic, mitral, and tricuspid valve insufficiency, dilation of the ascending aorta and aortic arch, aneurysm of the descending thoracic aorta, dilation of the brachiocephalic trunk, right common carotid artery, and right subclavian artery, coronary heart disease, angina pectoris, paroxysmal atrial fibrillation, and cardiomegaly. The patient received specific treatment for late cardiovascular syphilis as well as surgical treatment for aortic valve disease and descending thoracic aortic aneurysm.

  • Open Access

    Experimental modeling of congenital epidermolysis bullosa — a tool for studying the pathogenesis and gene therapy targets of the disease

    by Arfenya E. Karamova, Ekaterina V. Girko, Kseniya M. Aulova, Xenia I. Plahova

    Epidermolysis bullosa (EB) is a phenotypically and genetically heterogeneous group of hereditary dermatoses characterized by the formation of blisters on the skin and/or mucous membranes with minimal mechanical exposure. The study of the pathogenesis and development of therapeutic strategies for EB present significant challenges. In this regard, experimental animal models of EB, especially using laboratory mice, are important in modern science. Genetically modified lines reproducing key mutations in the corresponding genes (Krt5, Krt14, Plec, Lama3, Lamb3, Lamc2, Col7a1, etc.) successfully mimic phenotypic manifestations characteristic of human forms of EB and allow us to study the stages of the pathological process development, as well as to study the molecular basis of the disease and initiate the development of new effective methods of treatment. The advent of genome editing using CRISPR-Cas9, which allows targeted mutations in genes of interest, has simplified the disease modeling process. Further improvement of models is necessary for effective translation of experimental data into clinical practice.

  • Open Access

    Gonorrhea in the Russian Federation: incidence, active case detection and laboratory diagnostics

    by Elena Vitalievna Bogdanova, Nikita Yu. Nosov, Xenia Ilinichna Plahova

    Background. Gonorrhea is a possible cause of pelvic inflammatory complications, reproductive health disorders and adverse pregnancy outcomes. The problem of gonococcal antimicrobial resistance remains actual. Aims. Analysis of incidence, circumstances of case detection, and methods of laboratory examination for gonococcal infection used in the Russian Federation. Methods. Analysis of state federal statistical surveillance data for 2011–2024. Results. In 2011–2019, the incidence of gonorrhea decreased fivefold, the incidence of total STI — by 2.5 times. In 2020, the incidence of gonorrhea decreased by 13%, STI — 25%. After gonorrhea incidence increase in 2021 and 2022, it was reduced by 4% in 2023, by 15% in 2024. During COVID-19 pandemic, there was a decrease of proportion of patients detected in hospitals (from 1.6% in 2019 to 0.8% in 2020–2024); at medical examinations (from 3.0% in 2019 to 1.7% in 2023); and actively by dermatovenereologists (from 16.2% in 2019 to 12.4% in 2023). In 2019–2024, the proportion of cases confirmed by molecular-biological laboratory examination increased from 27 to 57%. In 2024, molecular-biological, microbiological or both methods were not used to diagnose gonococcal infection in state medical organizations respectively of 13, 42 and 5 constituent entities of the Russian Federation. Conclusion. The distinctive features of gonorrhea incidence dynamics during COVID-19 pandemic are lack of acceleration in decline rate in 2020, and incidence increase in 2021 and 2022, due to an increase in the number of cases among Russian citizens. Against the background of a resumption of gonorrhea incidence decrease in 2023 and 2024, there is no recovery of active case detection measures. The access to highly sensitive laboratory methods in medical organizations of state healthcare system of a number of constituent entities of the Russian Federation is not ensured.

  • Open Access

    Clinical experience in managing patients with lymphogranuloma venereum

    by Xenia I. Plakhova, Georgiy L. Katunin, Nazirbek K. Abuduyev, Mikhail M. Vasiliev, Плахова Ксения Ильинична, Васильев Михаил Михайлович

    The article presents two clinical cases of lymphogranuloma venereum with classic manifestations of the disease. In the first case, the stages of lymphogranuloma venereum can be traced: the appearance of a primary affect (ulcer on the penis), the development after a few weeks of regional (inguinal) lymphadenitis and proctitis (anorectal syndrome). On the background of prescribed antibiotic therapy according to the regimen: doxycycline at a dose of 100 mg twice a day for 21 days, the clinical manifestations completely resolved. The second case is interesting in the development of the clinical picture of lymphogranuloma venereum from the second stage of the disease (inguinal syndrome) and the ineffectiveness of treatment with doxycycline, which subsequently required surgical intervention. In addition, in this case, Chlamydia trachomatis DNA was initially detected in a urethral scraping without evidence of urethral inflammation, which is rare for this disease. To treat a patient with “inguinal syndrome” as a clinical manifestation of lymphogranuloma venereum, a fluoroquinolone antibiotic, levofloxacin, was successfully used according to the regimen 500 mg twice a day for 28 days.

  • Open Access

    The effectiveness of using a combination of laser radiation with wavelengths of 585 and 1064 nm in the treatment of patients with basal cell skin cancer

    by Rifat R. Saytburkhanov, Xenia I. Plakhova, Irina N. Kondrakhina, Аlexey A. Kubanov, Плахова Ксения Ильинична

    Background. Basal cell skin cancer is the most common skin malignancy, and its incidence has been rapidly increasing throughout the world in recent decades. Aims. To study the effectiveness of using laser radiation with a wavelength of 585 nm and 1064 nm in a sequential (sequential) combined mode for the treatment of patients with superficial and nodular forms of basal cell skin cancer using dermoscopic and confocal microscopic in vivo examination. Materials and methods. The study included 30 patients with histologically confirmed basal cell skin cancer, who received treatment in the conditions of the Consultative and Diagnostic Center of the State Research Center of Dermatovenereology and Cosmetology of Russian Ministry of Health in the period from 2020 to 2021, using a pulsed dye laser (wavelength 585 nm) and long-pulse neodymium laser (wavelength 1064 nm). Results. In the subgroup of patients with the nodular form of basal cell carcinoma (n = 15): in 11 patients the duration of treatment was 1 procedure, in 3 patients – 2 procedures, in 1 patient — 3 procedures. In the subgroup of patients with superficial basal cell carcinoma (n = 15 ): in 2 patients the course of treatment was 2 procedures, in 13 patients — 1 procedure. Patients have now completed treatment and are being followed up with visits every 6 months for 3 years. According to dermoscopic and confocal microscopic studies, there is no evidence of continued growth and relapse in all patients. No side effects or adverse events were recorded. Conclusions. The combined sequential use of 585 nm and 1064 nm laser radiation may be an effective treatment for patients with low-risk basal cell skin cancer of recurrence. The results of our study indicate that clinical tumor removal without scarring can be achieved and may be an alternative treatment option for those who do not wish to use traditional surgical approaches.

  • Open Access

    Gene expression changes of angiogenesis factors during basal skin cancer laser destruction

    by Rifat R. Saytburkhanov, Dmitry A. Verbenko, Xenia I. Plakhova, Irina N. Kondrakhina, Ksenia M. Lagun, Elena V. Filonenko, Аlexey A. Кubanov, Плахова Ксения Ильинична

    Background. Basal cell carcinoma is the most widespread malignant skin neoplasm. Angiogenesis is critical for the growth and metastasis of malignant tumors. Aims. To study the levels of representation of transcripts in the foci of basal cell skin cancer before and after the therapy of genes for angiogenesis proteins and their receptors: angiopoietin 2 ANGPT2, calcitonin-related polypeptide alpha CALCA, epidermal growth factor receptor EGRF, fibroblast growth factor FGF2, intracellular adhesion molecule ICAM1, vascular endothelial growth factor VEGFA and its type 2 receptor VEGFR2, matrix metalloproteinase MMP9, homologue protein of phosphatase and tensin PTEN, tachykinin receptor TAC1, and tumor necrosis factor protein genes TNF. Methods. The study included 31 patients with histologically confirmed basal cell skin cancer who received treatment at the consultative and diagnostic center of the State Research Center of Dermatovenereology and Cosmetology of Russian Ministry of Health, Moscow in the period from 2020 to 2021, using a pulsed dye laser (wavelength — 585 nm) and long-pulsed neodymium laser (wavelength — 1064 nm). The patients provided skin punch biopsies from BCC lesions and after therapy from the same localization. The gene expression was analyzed with real-time reverse transcription PCR using endogeneous control, and the gene expression ration changes during the therapy were calculated according to Livak’s double delta formulae. Results. An increased expression of the matrix metalloproteinase MMP9 and the tachykinin precursor TAC1 genes were revealed in skin biopsy samples of the superficial form of basal cell skin cancer during laser pulsed therapy. The expression of tumor necrosis factor TNF, epidermal growth factor receptor EGFR, fibroblast growth factor FGF2 genes increases to a lesser extent. The increasing expression of MMP9 and TAC1 genes also established in skin biopsy samples of the nodular form of basal cell skin cancer. It was shown that the expression of the calcitonin-related polypeptide alpha CALCA gene in the skin of patients is at basal level, which makes it possible to exclude the influence of the neuropeptide on the basal cell skin cancer pathogenesis. Despite the bidirectional changes in expression due to individuality of patients, the average values allow to conclude the expression of all the studied genes is increased after pulse laser destruction therapy. This means neoangiogenesis is continued at the skin even after the destruction of basal cell skin cancer lesions. This could be due to the presence of the basal cell carcinoma microenvironment, likely mast cells, at the affected skin area. Conclusions. Among the factors of neoangiogenesis potentially influencing the development of basal cell skin cancer, the leading role of expression of the MMP9 matrix metalloproteinase and TAC1 precursor protein of tachykinin has been shown. Simultaneous changes in the level of these proteins may be due to neuroimmune interactions in the epidermis, which is probably realized by mast cells as the microenvironment of the basal cell carcinoma. In the process of laser destruction, there is also a slightly pronounced increased expression of additional factors of neoangiogenesis.


  • Open Access

    Pathogenetic substantiation of combination therapy for rosacea

    by Alexey A. Kubanov, Xenia I. Plakhova, Irina N. Kondrakhina, Sofia V. Volkova, Плахова Ксения Ильинична

    Rosacea is a chronic inflammatory dermatosis predominantly damage to the skin of the face, which has a significant negative impact on the quality patients’ lives. The main goal of treatment is to achieve the most complete remission. However, due to the fact that the pathogenesis of the disease is not fully understood, the search for new methods of treatment is especially relevant. Combined use pulsed dye laser and ivermectin drug is presented as alternative pathogenetically substantiated method of therapy. The purpose of the study is to characterize immune disorders and the role of cytokines in the pathogenesis of rosacea, as well as the possibilities of combination therapy based on literature data. An analysis of literature sources from the MedLine, Pubmed, eLibrary databases for the period from 2002 to 2022 was carried out, using the keywords “ivermectin”, “pulsed dye laser”, “rosacea”, “cytokines”, “ivermectin” , “Pulsed Dye Laser”, “rosacea”, “cytokines”.


  • Open Access

    New approaches to the treatment of rosacea on the basis pathogenesis factors and clinical forms

    by Anna O. Yakovleva, Dmitry A. Verbenko, Irina N. Kondrakhina, Ksenia I. Plakhova, Alexey A Kubanov, Плахова Ксения Ильинична, Кубанов Алексей Алексеевич

    Uncovering the molecular mechanisms of the rosacea pathogenesis and treatment are still of great importance. The review encompasses the modern knowledge of rosacea classification, characterization of the severity of the course of the subtypes, and pathogenesis features. Recent methods of rosacea treatment are presented, including the use of botulinum neuroprotein for the correction of the erythematous-telangiectatic subtype of the dermatosis. The relevance of this problem is due to the chronic course of the disease and the peculiarity of the localization of rosacea manifestations that leads to a traumatic effect and often causes social exclusion of patients. The rise of the rosacea incidences, along with other reasons like characteristics of the course of dermatosis, accompanied by frequent long-term relapses, is due to the resistance to generally accepted methods of drug therapy, often resulting in shortened clinical remission. All the factors lead to decreasing of patients life quality that require the search for effective therapy approaches. Among modern rosacea therapy, the application of botulinum neuroprotein is widely used; however, the clinical studies confirming the effectiveness of this technique are not presented enough.


  • Open Access

    The use of 585 and 1064 nm laser for the treatment of basal cell skin cancer

    by Rifat R. Saytburkhanov, Irina N. Kondrakhina, Xenia I. Plakhova, Alexey A. Kubanov, Плахова Ксения Ильинична

    Background. Basal cell skin cancer is the most common malignant epithelial skin neoplasm in fair-skinned people and accounts for two-thirds of all skin cancers in this population. Tumor lesions have a supporting vascular network that serves as a target for vascular selective lasers. Aims. To assess the effects of laser radiation at a wavelength of 585 and 1064 nm on the vasculature of various forms of basal cell skin cancer using dermatoscopy and in vivo confocal microscopy. Materials and methods. The study included 20 patients with 20 lesions of histologically confirmed basal cell skin cancer treated with a pulsed dye laser (wavelength 585 nm) and a long-pulse neodymium laser (wavelength 1064 nm) in the conditions of the consultative and diagnostic center of the Federal State Budgetary Institution GNTSDK of the Ministry of Health RF in the period from 2021 to 2022. The effectiveness of therapy was assessed using non-invasive methods for examining the skin. Results. According to the results of the two-year follow-up period, 100% effectiveness of therapy in both groups is noted, in 2 patients treated with a neodymium laser, the formation of hypertrophic scars in the treatment area is noted. Conclusions. Treatment of patients with basal cell skin cancer with selective vascular lasers may be an effective treatment option. Additional studies with a larger sample of observations and a long monitoring period are needed to confirm the effectiveness of this treatment method.